Blackstone lands $3.4B life science fund, plots more fundraising by Nick Paul Taylor Friday, January 10, 2020 The financing, which could grow by another $1.2 billion, sets Blackstone up to continue placing bets such as its ventures with Novartis and Ferring.
Private equity giant Blackstone buys Clarus in biopharma push by Nick Paul Taylor Thursday, October 4, 2018 Blackstone plans to fund R&D programs that have outgrown the means of traditional venture capital firms.
Forty Seven raises another $75M to expand I-O trial slate by Nick Paul Taylor Wednesday, October 18, 2017 The series B round equips the Stanford University spinout to expand trials of its CD47-targeted approach to dialing up phagocytosis of cancer cells.
